2-(4-morpholinyl)-8-phenyl-4h-1-benzopyran-4-one and Xeroderma Pigmentosum studies

2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one: specific inhibitor of phosphatidylinositol 3-kinase; structure in first source

Xeroderma Pigmentosum: A rare, pigmentary, and atrophic autosomal recessive disease. It is manifested as an extreme photosensitivity to ULTRAVIOLET RAYS as the result of a deficiency in the enzyme that permits excisional repair of ultraviolet-damaged DNA.

Research Excerpts

Excerpt	Relevance	Reference
"Etoposide (VP16) is a topoisomerase II inhibitor and has been used for the treatment of non-small cell lung cancer (NSCLC)."	5.48	17-(Allylamino)-17-Demethoxygeldanamycin Enhances Etoposide-Induced Cytotoxicity via the Downregulation of Xeroderma Pigmentosum Complementation Group C Expression in Human Lung Squamous Cell Carcinoma Cells. ( Chen, JC; Li, YT; Lin, MC; Lin, YC; Lin, YW; Ma, PF; Peng, YS; Wu, CH; Zheng, HY, 2018)
"Etoposide (VP16) is a topoisomerase II inhibitor and has been used for the treatment of non-small cell lung cancer (NSCLC)."	1.48	17-(Allylamino)-17-Demethoxygeldanamycin Enhances Etoposide-Induced Cytotoxicity via the Downregulation of Xeroderma Pigmentosum Complementation Group C Expression in Human Lung Squamous Cell Carcinoma Cells. ( Chen, JC; Li, YT; Lin, MC; Lin, YC; Lin, YW; Ma, PF; Peng, YS; Wu, CH; Zheng, HY, 2018)

Research

Studies (1)

Authors

Other Studies

1 other study available for 2-(4-morpholinyl)-8-phenyl-4h-1-benzopyran-4-one and Xeroderma Pigmentosum

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors	Studies
Chen, JC	1
Ma, PF	1
Lin, YC	1
Wu, CH	1
Peng, YS	1
Zheng, HY	1
Lin, MC	1
Li, YT	1
Lin, YW	1